网站主页
化工产品目录
医药中间体
原料药中间体
(5R,8R,9R,10S,13S,14S)-13-甲基十四氢-3H-环戊二烯并[A]菲-3,17(2H)-二酮
(5R,8R,9R,10S,13S,14S)-13-甲基十二氢-1H-环戊二烯并[a]菲-3,17(2H,4H)-二酮
![(5R,8R,9R,10S,13S,14S)-13-甲基十二氢-1H-环戊二烯并[a]菲-3,17(2H,4H)-二酮](/SupplyImg/2024-01-16/202401161717533954472.png)
(5R,8R,9R,10S,13S,14S)-13-甲基十二氢-1H-环戊二烯并[a]菲-3,17(2H,4H)-二酮
(5R,8R,9R,10S,13S,14S)-13-Methyldodecahydro-1H-cyclopenta[a]phenanthrene-3,17(2H,4H)-dione
5696-51-5
5696-51-5
询价
1KG
起订
10KG
起订
上海 更新日期：2024-08-09
产品详情:
- 中文名称：
- (5R,8R,9R,10S,13S,14S)-13-甲基十二氢-1H-环戊二烯并[a]菲-3,17(2H,4H)-二酮
- 英文名称：
- (5R,8R,9R,10S,13S,14S)-13-Methyldodecahydro-1H-cyclopenta[a]phenanthrene-3,17(2H,4H)-dione
- CAS号：
- 5696-51-5
- 纯度规格：
- 99%+HPLC
- 产品类别：
- 黄金产品
公司简介
Founded by a group of veterans from the US biopharmaceutical industry in 2010, P&T is now a leading Shanghai-based CRO company providing drug discovery and development services worldwide
| 成立日期 | (11年) |
| 注册资本 | 200万人民币 |
| 员工人数 | 50-100人 |
| 年营业额 | ￥ 5000万-1亿 |
| 经营模式 | 工厂,定制 |
| 主营行业 | 医药中间体,原料药 |
(5R,8R,9R,10S,13S,14S)-13-甲基十二氢-1H-环戊二烯并[a]菲-3,17(2H,4H)-二酮相关厂家报价 更多
-
![(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-10,13-二甲基-2,16-二(哌啶-1-基)十六氢-1H-环戊烷[a]菲-3,17-二醇;](https://img.chemicalbook.com/SupplyImg1/2024-11-18/Large/202411181328201084865.jpg)
- (2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-10,13-二甲基-2,16-二(哌啶-1-基)十六氢-1H-环戊烷[a]菲-3,17-二醇;
- 湖北诺迪纳生物技术有限公司 VIP
- 2024-11-18
- 询价
-
![(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-10,13-二甲基-2,16-二(哌啶-1-基)十六氢-1H-环戊烷[a]菲-3,17-二醇;](https://img.chemicalbook.com/SupplyImg1/2024-09-06/Large/202409061241178888018.png)
- (2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-10,13-二甲基-2,16-二(哌啶-1-基)十六氢-1H-环戊烷[a]菲-3,17-二醇;
- 湖北惠择普医药科技有限公司 VIP
- 2024-11-03
- 询价
-
![(8R,9S,13S,14S)-3-甲氧基-13-甲基-6,7,8,9,11,12,13,14,15,16-十氢-17H-环戊并[a]菲-17-酮](https://img.chemicalbook.com/SupplyImg1/2024-07-31/Large/202407311440397771131.png)
- (8R,9S,13S,14S)-3-甲氧基-13-甲基-6,7,8,9,11,12,13,14,15,16-十氢-17H-环戊并[a]菲-17-酮
- 河南威梯希化工科技有限公司 VIP
- 2024-11-22
- 询价
